Use of cyclipostin derivatives for the treatment of mycobacterial infectious diseases

1. A method for the treatment of a bacterial infection caused by mycobacteria, nocardia or corynebacteria, the method comprising administering an effective amount of a compound of the formula (I)

wherein

R 1 is

1. a saturated carbon chain having 10 to 18 carbon atoms, which can be straight-chain or branched, and in which the carbon chain is optionally mono- or disubstituted by a radical selected from

1.1 OH,

1.2 ═O,

1.3 O—(C 1 -C 6 )alkyl, in which alkyl is linear or branched,

1.4 O—(C 2 -C 6 )alkenyl, in which alkenyl is linear or branched,

1.5 (C 1 -C 6 )alkyl, in which alkyl is linear or branched,

1.6 aryl,

1.7 (C 1 -C 6 )alkylene-benzene,

1.8 diphenyl,

1.9 NH—(C 1 -C 6 )alkyl, in which alkyl is linear or branched,

1.10 NH—(C 2 -C 6 )alkenyl, in which alkenyl is linear or branched,

1.11 NH 2 ,

1.12 ═S,

1.13 S—(C 1 -C 6 )alkyl, in which alkyl is linear or branched

R 2 is

(C 1 -C 6 )alkyl, wherein alkyl is unsubstituted, or mono- or disubstituted by a radical as described in 1.1-1.3;

in any stereochemical form, or a mixture of any stereochemical forms in any ratio, or a physiologically tolerable salt thereof.

2. The method of claim 1 , wherein the compound of the formula (I) is selected from the group consisting of

Cyclipostin A of the formula (II):

Cyclipostin A2 of the formula (II-A)

Cyclipostin B of the formula (III)

Cyclipostin C of the formula (IV)

Cyclipostin D of the formula (V)

Cyclipostin E of the formula (VI)

Cyclipostin F of the formula (VII)

Cyclipostin G of the formula (VIII)

Cyclipostin H of the formula (IX)

Cyclipostin N of the formula (X)

Cyclipostin P of the formula (XI)

Cyclipostin P2 of the formula (XI-A)

Cyclipostin Q of the formula (XII)

Cyclipostin R of the formula (XIII)

Cyclipostin R2 of the formula (XIII-A)

Cyclipostin S of the formula (XIV)

Cyclipostin T of the formula (XV)

Cyclipostin T2 of the formula (XV-A)

in any stereochemical form, or a mixture of any stereochemical forms in any ratio, or a physiologically tolerable salt thereof.

3. The method of claim 2 , wherein the compound of the formula (I) is selected from the group consisting of Cyclipostin P, Cyclipostin R, Cyclipostin T and Cyclipostin T2.

4. The method of claim 1 , wherein the bacterial infection is selected from the group consisting of tuberculosis, leprosy, nocardiosis, diphtheria, pulmonary mycobacterial infection, cutaneous mycobacterial infection, atypical mycobacterial infection and mycobacteriosis.

5. The method of claim 1 , wherein said bacterial infection is an infection caused by mycobacteria, nocardia or corynebacteria selected from the group consisting of Mycobacterium smegmatis, Mycobacterium phlei, Nocardia brasiliensis, Nocardia abscessus and Corynebacterium diphtheriae.